688266

Suzhou Zelgen Biopharmaceuticals
688266

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥27.20B
EV
CN¥26.07B
Shares Outstanding
264.71M
Beta
0.47

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN¥135.00
P/E 2025E
294.22x
P/Revenue 2025E
32.22x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

gainify
688266

Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

688266

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers donafenib tablets; recombinant human thrombin for topincal use; jacktinib tablets; and recombinant human thyroid-stimulati...

Sector

Healthcare

Industry

Biotechnology

CEO

Sheng, Zelin

Employees

867

IPO Date

2020-01-23

Headquarters

No. 209, Chenfeng Road, Kunshan, Jiangsu Province, 215300, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved